Epocrates Inc. Cancels IPO

December 16, 2008 |

1 min read

Epocrates Inc., a San Mateo, Calif.-based provider of clinical information and support tools to healthcare professionals, has withdrawn plans for a $75 million IPO. It had planned to trade on the Nasdaq, with Citi serving as lead underwriter.

IPO

MORE ON THIS TOPIC

Changing or transforming, turning around, challenging the odds and conquering adversity, a businessman pole vaulting from the down arrow to the up arrow of growth

IPO

SPACs Line Up To Clear Biotech’s IPO Backlog

September 3, 2025

·

6 min read

·

Annalee Armstrong

A hand about to burst a money bubble with a pin. Metaphor for an economic or financial bubble crisis.

IPO

After 2021 SPAC Bubble, How Did These 6 Biotechs Fare?

September 3, 2025

·

10 min read

·

Tristan Manalac

A red paper airplane with a fighter jet shadow changes course from a group of other paper airplanes, a concept of different business and social behaviors. Vector illustration.

IPO

After Short Stint as a Private Company, BBOT Leaves SPAC Process Ready To Execute

September 3, 2025

·

3 min read

·

Annalee Armstrong

Building a rocket. Halftone hands assemble a rocket shaped puzzle. Concept of a startup, new business. Hasty rocket launch. Innovation, teamwork, development of ideas and technologies

Deals

Vertex, Enlaza Declare War on Autoimmune Disease in Potential $2B+ Pact

September 2, 2025

·

2 min read

·

Heather McKenzie